AMO Surgical Devices Outshine Lens Care Products In First Earnings Report
This article was originally published in The Gray Sheet
Executive Summary
Advanced Medical Optics' sales of intraocular lenses and phacoemulsification devices supported an 8.2% increase in ophthalmic surgical device revenue in the second quarter - the period just prior to AMO's June 29 spin-off from Allergan
You may also be interested in...
Post-Allergan, Advanced Medical Optics Reviews Manufacturing Options
Advanced Medical Optics' $22 mil. purchase of Alcon's eye care product factory in Madrid will replace manufacturing capacity that will be terminated when AMO ends its contract with Allergan within the next two years
Post-Allergan, Advanced Medical Optics Reviews Manufacturing Options
Advanced Medical Optics' $22 mil. purchase of Alcon's eye care product factory in Madrid will replace manufacturing capacity that will be terminated when AMO ends its contract with Allergan within the next two years
Ophthalmic Spin-Offs Alcon, AMO See Stock Gains In 2002, Join MDDI Index
Ophthalmic device makers Alcon and Advanced Medical Optics (AMO) were both able to achieve double-digit stock price percentage gains in 2002 after debuting as independent firms, in part due to expanding sales of surgical products such as IOLs